Genetic heart muscle disease and heart rhythm study
Part of Heart & circulation clinical trials.
This study looks at the risk of a fast heart rhythm (ventricular tachycardia) in people with genetic heart muscle diseases. It tests whether having a specific genetic change affects the success of a heart ablation procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with atrial fibrillation, frequent PVCs, or ventricular tachycardia before age 60
- Scheduled for a catheter ablation procedure for AF, PVCs, or VT
- Able to understand and sign a consent form
- Either have a known genetic change in the TTN gene or another heart muscle gene, or be a control without such a change
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special catheter to map abnormal heart rhythms like ventricular tachycardia or atrial fibrillation. It may help patients who need a procedure to find and treat the source of these fast or irregular heartbeats.
This study looks at genetic factors in people with atrial fibrillation (an irregular heartbeat) and weak heart function to understand why some people's hearts recover after treatment and others don't. Researchers will collect blood samples and medical information to identify genetic patterns.
This trial looks at how the heart's electrical signals work in people with hypertrophic cardiomyopathy (a condition where the heart muscle becomes thickened) who also have atrial fibrillation (a type of irregular heartbeat). The goal is to understand these signals better during a planned ablation procedure, which is a treatment to fix the irregular rhythm.
This study looks at the genes of people whose heart muscle becomes weak due to a fast or irregular heartbeat (atrial fibrillation or flutter). The goal is to better understand why this happens in some people and not others.
This study observes people with atrial fibrillation or ventricular tachycardia who are having their first catheter ablation procedure. The goal is to collect information to improve future treatments.
This study tests a new catheter-based treatment for people with certain types of very fast or extra heartbeats that come from the lower chambers of the heart. The catheter uses a special energy to stop the abnormal beats and might help if you have had symptoms despite other treatments.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.